AAV-Mediated Gene Replacement Therapy in a Mouse Model of Usher Syndrome Type II Lacking Whirlin

被引:0
|
作者
Zou, J. [1 ]
Luo, L. [1 ]
Chiodo, V. [2 ]
Ambati, B. [1 ]
Hauswirth, W. [2 ]
Yang, J. [1 ]
机构
[1] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT USA
[2] Univ Florida, Dept Ophthalmol, Gainesville, FL USA
关键词
gene transfer/gene therapy; photoreceptors; retinal degenerations: cell biology;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3102
引用
收藏
页数:2
相关论文
共 50 条
  • [1] AAV-Mediated Gene Replacement Therapy in Mouse Model of Tuberous Sclerosis
    Prabhakar, Shilpa
    Zhang, Xuan
    Goto, June
    Sena-Esteves, Miguel
    Ramesh, Vijaya
    Bronson, Roderick
    Chen, John W.
    Stemmer-Rachamimov, Anat O.
    Kwiatkowski, David J.
    Breakefield, Xandra O.
    [J]. MOLECULAR THERAPY, 2015, 23 : S78 - S78
  • [2] AAV-mediated gene therapy in a mouse model of sialidosis
    van de Vlekkert, Diantha
    Hu, Huimin
    Weesner, Jason A.
    Gomero, Elida M.
    d'Azzo, Alessandra
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 129 - 130
  • [3] AAV-mediated Gene Replacement Therapy is Beneficial in Unverricht-Lundborg Disease Mouse Model
    Gumusgoz, Emrah
    Kasiri, Sahba
    Wu, Jun
    Dear, Matthew
    Chen, Xin
    Minassian, Berge
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (10 S): : S2 - S2
  • [4] Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy
    Di Meo, Ivano
    Auricchio, Alberto
    Lamperti, Costanza
    Burlina, Alberto
    Viscomi, Carlo
    Zeviani, Massimo
    [J]. EMBO MOLECULAR MEDICINE, 2012, 4 (09) : 1008 - 1014
  • [5] Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID
    Roca, Carles
    Motas, Sandra
    Marco, Sara
    Ribera, Albert
    Sanchez, Victor
    Sanchez, Xavier
    Bertolin, Joan
    Leon, Xavier
    Perez, Jennifer
    Garcia, Miguel
    Villacampa, Pilar
    Ruberte, Jesus
    Pujol, Anna
    Haurigot, Virginia
    Bosch, Fatima
    [J]. HUMAN MOLECULAR GENETICS, 2017, 26 (08) : 1535 - 1551
  • [6] AAV-mediated gene therapy to treat mucopolysaccharidosis type IVA in a new mouse model of the disease
    Sanchez, V.
    Bertolin, J.
    Ribera, A.
    Sanchez, X.
    Marco, S.
    Motas, S.
    Perez, J.
    Roca, C.
    Elias, G.
    Garcia, M.
    Leon, X.
    Haurigot, V.
    Ruberte, J.
    Bosch, F.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A172 - A172
  • [7] Development of AAV Mediated Gene Therapy Approach for Usher Syndrome Type 2
    Chekuri, Anil
    Wang, Weiwei
    Vandenberghe, Luk H.
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 636 - 637
  • [8] AAV-Mediated Gene Therapy to Treat Mucopolysaccharidosis Type IVA in a New Morquio a Mouse Model
    Sanchez, Victor
    Bertolin, Joan
    Ribera, Albert
    Sanchez, Xavier
    Marco, Sara
    Motas, Sandra
    Perez, Jennifer
    Roca, Carles
    Elias, Gemma
    Garcia, Miquel
    Leon, Xavier
    Haurigot, Virginia
    Ruberte, Jesus
    Bosch, Fatima
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 492 - 492
  • [9] Miniaturization of Usher Syndrome Type 2A gene for AAV mediated gene therapy
    Wang, Weiwei
    Vandenberghe, Luk H.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [10] Miniaturization of Usher Syndrome Type 2A ene for AAV Mediated Gene Therapy
    Wang, Weiwei
    Florea, Michael
    Vandenberghe, Luk H.
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 270 - 270